###### Article summary

Article focus
=============

-   Cortical hypometabolism associated with dysphagia in Parkinson\'s disease (PD) was statistically examined at baseline and after a 3-year follow-up period.

Key messages
============

-   The multiple cortical impairments, mainly in the supplementary motor area (SMA) and anterior cingulate cortex (ACC), might be responsible for the dysphagia in PD.

-   The time needed for swallowing initiation was significantly longer in patients with dysphagia.

-   Dysphagia in PD patients is mainly related to a difficulty in swallowing initiation that is based on a combination of poor movement planning owing to SMA dysfunction and impaired cognitive processing due to ACC dysfunction.

Strengths and limitations of this study
=======================================

-   The strength of this study is that it is the first to statistically examine the associations between cortical hypometabolism and dysphagia in PD patients as a cross-sectional and longitudinal comparative study.

-   A limitation is that the findings may not be related to dysphagia alone because ^18^F-fluorodeoxyglucose-positron emission tomography cannot be used for dynamic scanning during swallowing. Another weakness of this study is the absence of videofluoroscopy as a swallowing evaluation.

Introduction {#s1}
============

Parkinson\'s disease (PD) is primarily characterised by motor dysfunctions, some of which, such as tremor, rigidity and bradykinesia, respond well to dopamine replacement therapy, whereas others, such as postural instability, dysarthria and dysphagia, remain intractable and often impair the quality of life in advanced cases. The involvement of non-dopaminergic systems is implied in such dopamine-refractory symptoms; however, the detailed pathophysiological mechanisms of these systems are still elusive. In particular, swallowing difficulty is directly associated with malnutrition and difficulty in drug taking; moreover, this symptom sometimes results in aspiration pneumonia, the main cause of death in PD patients.[@R1; @R2; @R3] The voluntary transport of food through the oral cavity, pharynx and oesophagus to the stomach requires sequential motor events. Deglutition occurs through five consecutive phases: anticipatory (cognitive), preparatory (masticatory), oral, pharyngeal and oesophageal. Dysphagia is associated with all of these stages.[@R4; @R5; @R6; @R7; @R8]

In general, dysphagia in PD is thought to reflect impaired function of the medullary swallowing centre.[@R9] The involvement of the higher central nervous system areas is also implied, but remains to be elucidated. In the present study, we investigated the swallowing functions of PD patients and compared them with the changes in the cortical metabolism using ^18^F-fluorodeoxyglucose positron emission tomography (FDG-PET). Moreover, we investigated clinical and imaging data not only at baseline, but also after a 3-year follow-up period, making this research a longitudinal study.

Methods {#s2}
=======

Participants {#s2a}
------------

All of the 43 PD patients were diagnosed based on the UK PD Brain Bank criteria for idiopathic PD.[@R10] The extent of dementia was evaluated in all of the indivuduals, using the clinical dementia rating (CDR). PD patients with a CDR score greater than 0.5 were excluded to minimise artefacts related to cognitive impairment. We defined a score of 0 as no dysphagia and a score of \>1 as dysphagia, according to part II of the unified Parkinson\'s disease rating scale (UPDRS). The UPDRS total scores, Mini-Mental State Examination (MMSE), swallowing function and PET studies were evaluated during the 'on' state, that is, with the administration of antiparkinsonian drugs without L-dopa-induced dyskinesia. Ten age-matched control subjects (4 women and 6 men; mean age 64.4±4.12 years; mean MMSE score 28.7±1.49) were collected to compare with PD patients with and without dysphagia for PET analysis. All of the procedures were approved by the Ethical Committee of the Tohoku University Graduate School of Medicine. Written informed consent was obtained from each individual after a full explanation of the entire 3- year longitudinal study.

PET procedure {#s2b}
-------------

The FDG-PET scans were performed in all 23 PD patients and 10 age-matched control subjects. All of the individuals fasted for at least 5 h prior to PET scanning. To minimise the effects of external stimuli during a 1 h FDG uptake period after intravenous injection of 185--218 MBq FDG, the individuals stayed in a quiet room wearing an eye mask under resting conditions. PET scans were acquired for 10 min under resting conditions. Dynamic PET scans were taken in three-dimensional mode using a BiographDuo PET scanner (Siemens Medical Systems, Inc, Iselin, New Jersey, USA). The in-plane and axial resolutions of the scanner were 3.38 and 3.38 mm, respectively. Attenuation correction was performed with a CT scan. Image reconstructions were performed using ordered subset expectation maximisation algorithms (16 subsets × 6 iterations) using a Gaussian filter with full-width at half-maximum = 2.0 mm in a 256×256 matrix, with a pixel size of 1.33×1.33 mm, a slice thickness of 2.0 mm and a field of view of 340 mm. The FDG-PET scans acquired at the follow-up were performed in an identical manner.

Data analysis {#s2c}
-------------

Statistical parametric mapping (SPM) was used for group comparisons of PET images. First, all of the PET images were spatially normalised with linear and non-linear parameters using SPM2 software (Welcome Department of Imaging Neuroscience, London, UK) implemented in MATLAB (The MathWorks, Inc, Sherborn, Maryland, USA). A three-dimensional Gaussian filter of 10 mm was used to smooth each image. Global normalisation was performed using SPM\'s 'proportional scaling', and proportional threshold masking was set at 0.8. Next, the regional metabolic abnormalities in the PD patients with and without dysphagia at baseline and after the 3-year follow-up period were estimated by comparison with 10 age-matched control subjects using proportional scaling. The statistical threshold was p\<0.001 (uncorrected) with an extent threshold of 40 voxels.

Evaluation of swallowing {#s2d}
------------------------

We evaluated the time needed for swallowing initiation and the 30 s swallowing frequency in all 23 PD patients and 10 healthy volunteers. The index and ring finger pads of the investigator were placed on the thyroid cartilage and laryngeal prominence. The time needed for swallowing initiation was defined as the time until movement of the thyroid cartilage and laryngeal prominence following the verbal guidance cue to begin swallowing using a timer. The time of swallowing initiation across three trials was averaged. We also measured the swallowing frequency by asking the patients to swallow as many times as possible in 30 s and counting the movements of the thyroid cartilage and laryngeal prominence.[@R11] [@R12]

The patient profiles were statistically analysed using two-sample t tests. For the swallowing function, the within-group differences of the patients with and without dysphagia were assessed using paired t tests.

Results {#s3}
=======

Of the 43 potentially eligible cases, 16 were excluded from the analysis because of dementia. The 27 patients who fulfilled the above entry criteria included 9 patients with dysphagia and 18 patients without dysphagia. The mean (±SD) age was 68.2±3.23 years in patients with dysphagia and 65.8±3.94 years in patients without dysphagia. All of the patients were right-handed. Eight of 9 PD patients with dysphagia and 15 of 18 patients without dysphagia at baseline participated in the 3-year follow-up study. The details of the excluded patients were as follows: 2 patients without dysphagia went to other hospitals and 1 patient without dysphagia and 1 patient with dysphagia were unable to be evaluated during the follow-up period because of the introduction of a feeding tube ([figure 1](#BMJOPEN2012002249F1){ref-type="fig"}).

![Parkinson\'s disease patients and follow-up flow diagram.](bmjopen2012002249f01){#BMJOPEN2012002249F1}

Clinical features and medications were summarised in [table 1](#BMJOPEN2012002249TB1){ref-type="table"}. No significant differences were found in the age, Hoehn-Yahr stage and dosage of antiparkinsonian agents, including L-dopa ([table 1](#BMJOPEN2012002249TB1){ref-type="table"}) or 30 s swallowing frequency ([figure 2](#BMJOPEN2012002249F2){ref-type="fig"}B), but significant differences were found between the two groups in disease duration, UPDRS motor score and time needed for swallowing initiation at baseline (p\<0.05, [table 1](#BMJOPEN2012002249TB1){ref-type="table"} and [figure 2](#BMJOPEN2012002249F2){ref-type="fig"}A). After the 3-year follow-up period, the differences in the time needed for swallowing initiation were still clear, but no significant differences became evident in the UPDRS motor scores ([table 1](#BMJOPEN2012002249TB1){ref-type="table"} and [figure 2](#BMJOPEN2012002249F2){ref-type="fig"}A). Significant differences were revealed in the swallowing frequency within 30 s between the two groups (p\<0.05, [table 1](#BMJOPEN2012002249TB1){ref-type="table"} and [figure 2](#BMJOPEN2012002249F2){ref-type="fig"}B). The times needed for swallowing initiation (1.02±0.36 s) and the 30 s swallowing frequency (5.10±2.42) in 10 healthy volunteers were almost the same as those of PD without dysphagia. There was no significant difference in the L-dopa equivalent dose between baseline and 3-year follow-up in PD with dysphagia using paired t test (p\>0.05), while a significant difference was found in PD without dysphagia (p\<0.05). No significant differences were found in the UPDRS motor score between baseline and 3-year follow-up within groups using paired t tests (p\>0.05).

###### 

Profiles of PD patients

                                      Baseline     Follow-up                
  --------------------------------- ------------- ----------- ------------- -------------
  Number of patients                      8           15                    
  Sex (M/W)                             6/ 2         4 /11                  
  Age (years)                                                               
   Mean                               67.8±3.11    65.2±4.02                
   Range                               63--71       60--74                  
  Disease duration (years)           6.75±3.73\*   3.53±3.58                
  MMSE                                28.5±1.93    28.5±1.51  27.9 ± 2.80   28.4 ± 1.60
  Hoehn-Yahr stage                    2.75±0.27    2.37±0.67  3.06 ± 0.42   2.93 ± 0.53
  UPDRS motor score                  23.4±7.05\*   14.8±7.49  21.0 ± 5.93   17.4 ± 11.1
  L-dopa equivalent dose (mg/day)      400±311      267±321   590±155       514±311

Values are mean±SD or the number of patients.

\*Significant difference p\<0.05 between with and without dysphagia.

M, men; MMSE, Mini-Mental State Examination; PD, Parkinson\'s disease; UPDRS, unified Parkinson\'s disease rating scale; W, women.

![The time needed for swallowing initiation and the 30 s swallowing frequency in Parkinson\'s disease (PD) patients with and without dysphagia at baseline and after a 3-year follow-up period. There were significant differences between PD patients with and without dysphagia in the time needed for swallowing initiation at baseline and after a 3-year follow-up period (p\<0.05) (A). In the 30 s swallowing frequency, there was no significant difference between PD patients with and without dysphagia at baseline (p\>0.05), but a significant difference between the two groups was evident after the 3-year follow-up period (p\<0.05) (B).](bmjopen2012002249f02){#BMJOPEN2012002249F2}

A comparison of the regional cerebral glucose of PD patients with that of normal controls demonstrated hypometabolism in the supplementary motor area (SMA) and the anterior cingulate cortex (ACC) in patients with dysphagia at baseline (uncorrected p\<0.001, [figure 3](#BMJOPEN2012002249F3){ref-type="fig"}A). These metabolic changes showed no significant correlations with the severity of the Hoehn-Yahr stages (uncorrected p\<0.001, data not shown) or the UPDRS motor scores (uncorrected p\<0.001, data not shown). Furthermore, no regional hypermetabolism was found in PD patients with dysphagia compared with normal control subjects (uncorrected p\<0.001, data not shown). Additionally, no relationships were observed between the changes in the regional cerebral glucose metabolism and the doses of antiparkinsonian agents, including L-dopa (p\>0.05, data not shown). After the 3-year follow-up period, the areas of hypometabolism included not only the SMA and the ACC but also the bilateral medial frontal lobes, middle cingulate cortex, thalamus and right superior, middle, inferior and orbital frontal gyri (uncorrected p\<0.001, [figure 3](#BMJOPEN2012002249F3){ref-type="fig"}B). Only a small degree of hypermetabolism in the left middle and right superior occipital lobes, left middle temporal lobe, left supramarginal gyrus and left calcarine cortex was found in PD patients with dysphagia compared to the normal control subjects (uncorrected p\<0.001, data not shown). In contrast, PD patients without dysphagia showed virtually no regional hypometabolism at baseline (uncorrected p\<0.001, [figure 4](#BMJOPEN2012002249F4){ref-type="fig"}A) and only a small degree of hypometabolism in the SMA and ACC after the 3-year follow-up period (uncorrected p\<0.001, [figure 4](#BMJOPEN2012002249F4){ref-type="fig"}B) compared with normal controls. On the other hand, in PD patients without dysphagia, no regional hypermetabolism was found at baseline (uncorrected p\<0.001, data not shown) and only a small degree of hypermetabolism in the left supramarginal gyrus, left postcentral gyrus, and left middle and superior lobes was found after the 3-year follow-up period (uncorrected p\<0.001, data not shown). Medullary hypometabolism was not found either at baseline or after a 3-year follow-up period (uncorrected p\<0.001, [figures 3](#BMJOPEN2012002249F3){ref-type="fig"} and [4](#BMJOPEN2012002249F4){ref-type="fig"}).

![Cross-sectional analyses of brain maps showing the differences between Parkinson\'s disease (PD) patients with dysphagia and normal control subjects at baseline (A) and after a 3-year follow-up period (B). Various areas showed differences in the standardised PET data, and areas with a height threshold of p\<0.001 (uncorrected) and an extent threshold of 40 voxels are illustrated. A comparison of regional cerebral glucose metabolism values demonstrated hypometabolism in the SMA and ACC in the PD patients with dysphagia compared with normal control subjects at baseline (uncorrected p\<0.001, threshold=40 voxels) (A). After a 3-year follow-up period, the areas of hypometabolism included not only the SMA and the ACC but also the bilateral medial frontal lobes, middle cingulate cortex, thalamus and right superior, middle, inferior and orbital frontal gyri (uncorrected p\<0.001, threshold=40 voxels) (B).](bmjopen2012002249f03){#BMJOPEN2012002249F3}

![Cross-sectional analyses of brain maps showing differences between PD patients without dysphagia and normal control subjects at baseline (A) and after a 3-year follow-up period (B). Various areas showed differences in the standardised PET data, and areas with a height threshold of p\<0.001 (uncorrected) and an extent threshold of 40 voxels are illustrated. The PD patients without dysphagia showed virtually no hypometabolism at baseline (uncorrected p\<0.001, threshold=40 voxels) (A) and only a small degree of hypometabolism in the SMA and ACC after a 3-year follow-up period (uncorrected p\<0.001, threshold=40 voxels) (B) compared with normal control subjects.](bmjopen2012002249f04){#BMJOPEN2012002249F4}

Discussion {#s4}
==========

The present results suggested that although several motor cortical areas control deglutition, multiple cortical impairments, mainly in the SMA and ACC, might be responsible for dysphagia in PD. These results were in agreement with the findings of previous activation studies such as functional MRI[@R13; @R14; @R15; @R16; @R17; @R18] and PET[@R19] [@R20] of normal deglutition. Impairments in these areas did not appear to be closely associated with the degree of general motor dysfunction and cognitive impairments, as no significant correlations were found between the UPDRS motor scores or the MMSE scores and the degree of hypometabolism in these areas (uncorrected p\<0.001, data not shown). Moreover, although there were no significant changes in the UPDRS motor scores and the MMSE scores, except for the L-dopa equivalent dose in PD without dysphagia, between baseline and 3-year follow-up in each group ([table 1](#BMJOPEN2012002249TB1){ref-type="table"}), cortical hypometabolism in the medial frontal lobes was markedly extended, especially in cases with dysphagia ([figure 3](#BMJOPEN2012002249F3){ref-type="fig"}). Interestingly, in patients with dysphagia, both of the swallowing indices showed tendencies toward exacerbation during the 3-year follow-up period, although the differences were not significant ([figure 2](#BMJOPEN2012002249F2){ref-type="fig"}). Although no significant difference was found in the UPDRS motor score between PD with and without dysphagia after a 3-year follow-up, the time needed for swallowing initiation was worsening in PD with dysphagia. Bradykinesia did not appear to be directly related to the outcome measurement results for evaluation of swallowing. We could not find any compensatory mechanisms for dysphagia because regional hypermetabolism was not found in PD with and without dysphagia at baseline.

Major subcortical inputs to the SMA via the thalamus arise from the globus pallidus and the substantia nigra.[@R21] The SMA also receives limbic inputs from the cingulate cortex.[@R22] The SMA is known to be important in mediating and preparing complex sequences of movement[@R23] and in movement planning and execution.[@R24; @R25; @R26; @R27; @R28] PET and functional MRI studies demonstrated SMA activation during the swallowing task.[@R19] [@R29] Activation of the SMA preceding the onset of volitional swallowing can also be demonstrated by the assessment of the Bereitschaftspotential, one of the premotor potentials that is considered to reflect the activities of the SMA.[@R30] The amplitude of the Bereitschaftspotential[@R31] was shown to be significantly lower in PD patients compared with age-matched controls.[@R32] PET and single-photon emission CT studies also demonstrated dysfunction of the SMA in PD.[@R33; @R34; @R35; @R36; @R37] Therefore, the SMA dysfunction in PD patients with dysphagia is likely to be related to the impaired volitional initiation of swallowing.

The ACC is connected to both the insula[@R38] and the amygdalae,[@R39] which are implicated in autonomic function and somatosensory and viscerosensory input. Intense stimulation of the oesophagus[@R8] [@R40] and changes in gastrointestinal motility[@R39] were shown to activate the ACC. The ACC is thought to play an important role in receiving sensory stimuli from the alimentary tract. The functions of the rostral ACC are autonomic regulation and visceromotor control.[@R14] In fact, the rostral ACC is activated during automatic swallowing.[@R14] In contrast, the more dorsal and caudal regions of the ACC function in skeletomotor control, including movement regulation and premotor function, response selection, attention to willed action and nociception.[@R26] The intermediate and caudal regions of the ACC are activated during voluntary swallowing.[@R14] [@R18] [@R41] As PD patients with dysphagia showed hypometabolism in the intermediate and caudal regions of the ACC, corresponding to Brodmann's area 24 as shown in [figure 3](#BMJOPEN2012002249F3){ref-type="fig"}A, the dysphagia in PD patients appears to be associated with difficulties in the processing of voluntary swallowing. In fact, the mean time needed to initiate swallowing was longer in cases with dysphagia ([figure 2](#BMJOPEN2012002249F2){ref-type="fig"}).

In this study, the time needed for swallowing initiation and swallowing frequency for 30 s showed high reproducibility. The time needed for swallowing initiation was thought to reflect the time from the anticipatory to the pharyngeal stages of deglutition, but other stages were not evaluated. Additional evaluation, such as videofluoroscopy, is needed to understand the relationship between brain hypometabolism and dysphagia in PD patients. Interestingly, in 4 of 8 patients with dysphagia, the time needed for swallowing initiation was above average (2.35 s), and, in fact, percutaneous endoscopic gastrostomies were performed in 2 of these 4 patients within 4 years of the baseline study. Thus, by measuring the time needed for swallowing initiation, we may be able to predict the long-term prognosis of swallowing difficulty.

Conclusion {#s5}
==========

In conclusion, the data presented in this study suggested that dysphagia in PD patients was related to dysfunctions in the SMA and ACC, resulting in poor movement planning of voluntary swallowing. The results also suggest that training exercises, which can activate broader cortical areas including the SMA and ACC,[@R17] may be useful to alleviate swallowing difficulty.
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